Plain-English translation of NCT07755904 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is comparing a new medication called to , a heart medication that has been used for many years. The study will test whether works better at relieving symptoms in adults who have obstructive hypertrophic cardiomyopathy — a condition where the heart muscle becomes abnormally thick and makes it harder for blood to flow normally. This medication is being tested in adults who either already take heart medications or who have never been treated before.
has been the standard treatment for this condition for a long time, but researchers believe this new treatment could offer better symptom relief or be easier for patients to take. This trial will help determine if the medication is a better option for people living with this serious heart condition.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either the new medication or , along with matching placebo pills so neither you nor the research team knows which treatment you're receiving at first. You will take your assigned medication(s) by mouth on a regular schedule and visit the study clinic for heart ultrasounds and check-ups to see how well the treatment is working. The trial will track how your symptoms improve and monitor your heart's response to the medication over time.
AI-generated summary from trial data · Oct 3, 2026 · Not medical advice
United States